[The effect of molsidomine on the conjunctival microcirculation in patients with ischemic heart disease].
Sublingual administration of molsidomin in average dose of 3 mg with an interval of 15 and 60 minutes was used in the treatment of 24 patients with ischemic heart disease with stable exertion stenocardia of the II-III functional classes. Course treatment in optimal chosen doses resulted in an improvement of the indices of conjunctival microcirculation and rheological properties of erythrocytes.